nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC2—type 2 diabetes mellitus	0.294	1	CbGaD
Gadoxetate—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0815	0.159	CbGbCtD
Gadoxetate—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0664	0.13	CbGbCtD
Gadoxetate—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0531	0.104	CbGbCtD
Gadoxetate—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0525	0.102	CbGbCtD
Gadoxetate—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0475	0.0927	CbGbCtD
Gadoxetate—ABCC3—Glyburide—type 2 diabetes mellitus	0.047	0.0917	CbGbCtD
Gadoxetate—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0438	0.0855	CbGbCtD
Gadoxetate—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0387	0.0755	CbGbCtD
Gadoxetate—SLCO1B3—Losartan—type 2 diabetes mellitus	0.0382	0.0745	CbGbCtD
Gadoxetate—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0222	0.0434	CbGbCtD
Gadoxetate—ABCC2—Glyburide—type 2 diabetes mellitus	0.0213	0.0417	CbGbCtD
Gadoxetate—Gadofosveset trisodium—ALB—type 2 diabetes mellitus	0.000921	1	CrCbGaD
Gadoxetate—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.91e-05	0.000708	CcSEcCtD
Gadoxetate—Chest pain—Metformin—type 2 diabetes mellitus	9.9e-05	0.000707	CcSEcCtD
Gadoxetate—Malaise—Irbesartan—type 2 diabetes mellitus	9.89e-05	0.000706	CcSEcCtD
Gadoxetate—Vertigo—Irbesartan—type 2 diabetes mellitus	9.85e-05	0.000704	CcSEcCtD
Gadoxetate—Headache—Pioglitazone—type 2 diabetes mellitus	9.85e-05	0.000703	CcSEcCtD
Gadoxetate—Syncope—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000702	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	9.83e-05	0.000702	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.79e-05	0.000699	CcSEcCtD
Gadoxetate—Discomfort—Metformin—type 2 diabetes mellitus	9.78e-05	0.000698	CcSEcCtD
Gadoxetate—Fatigue—Gliclazide—type 2 diabetes mellitus	9.77e-05	0.000698	CcSEcCtD
Gadoxetate—Nausea—Glipizide—type 2 diabetes mellitus	9.74e-05	0.000696	CcSEcCtD
Gadoxetate—Vomiting—Glimepiride—type 2 diabetes mellitus	9.73e-05	0.000695	CcSEcCtD
Gadoxetate—Hypotension—Valsartan—type 2 diabetes mellitus	9.73e-05	0.000695	CcSEcCtD
Gadoxetate—Vision blurred—Losartan—type 2 diabetes mellitus	9.73e-05	0.000695	CcSEcCtD
Gadoxetate—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.7e-05	0.000693	CcSEcCtD
Gadoxetate—Constipation—Gliclazide—type 2 diabetes mellitus	9.7e-05	0.000692	CcSEcCtD
Gadoxetate—Tremor—Losartan—type 2 diabetes mellitus	9.67e-05	0.000691	CcSEcCtD
Gadoxetate—Rash—Glimepiride—type 2 diabetes mellitus	9.65e-05	0.000689	CcSEcCtD
Gadoxetate—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.64e-05	0.000689	CcSEcCtD
Gadoxetate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000688	CcSEcCtD
Gadoxetate—Rash—Sitagliptin—type 2 diabetes mellitus	9.62e-05	0.000687	CcSEcCtD
Gadoxetate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.61e-05	0.000687	CcSEcCtD
Gadoxetate—Headache—Glimepiride—type 2 diabetes mellitus	9.59e-05	0.000685	CcSEcCtD
Gadoxetate—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.58e-05	0.000684	CcSEcCtD
Gadoxetate—Cough—Irbesartan—type 2 diabetes mellitus	9.57e-05	0.000684	CcSEcCtD
Gadoxetate—Headache—Sitagliptin—type 2 diabetes mellitus	9.56e-05	0.000683	CcSEcCtD
Gadoxetate—Agitation—Losartan—type 2 diabetes mellitus	9.49e-05	0.000677	CcSEcCtD
Gadoxetate—Oedema—Metformin—type 2 diabetes mellitus	9.49e-05	0.000677	CcSEcCtD
Gadoxetate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.45e-05	0.000675	CcSEcCtD
Gadoxetate—Flushing—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000674	CcSEcCtD
Gadoxetate—Infection—Metformin—type 2 diabetes mellitus	9.42e-05	0.000673	CcSEcCtD
Gadoxetate—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.35e-05	0.000668	CcSEcCtD
Gadoxetate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.34e-05	0.000667	CcSEcCtD
Gadoxetate—Chest pain—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000667	CcSEcCtD
Gadoxetate—Shock—Metformin—type 2 diabetes mellitus	9.33e-05	0.000666	CcSEcCtD
Gadoxetate—Malaise—Losartan—type 2 diabetes mellitus	9.31e-05	0.000665	CcSEcCtD
Gadoxetate—Anxiety—Irbesartan—type 2 diabetes mellitus	9.31e-05	0.000665	CcSEcCtD
Gadoxetate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.3e-05	0.000664	CcSEcCtD
Gadoxetate—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.3e-05	0.000664	CcSEcCtD
Gadoxetate—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.29e-05	0.000663	CcSEcCtD
Gadoxetate—Vertigo—Losartan—type 2 diabetes mellitus	9.27e-05	0.000662	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000662	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.27e-05	0.000662	CcSEcCtD
Gadoxetate—Syncope—Losartan—type 2 diabetes mellitus	9.26e-05	0.000661	CcSEcCtD
Gadoxetate—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.24e-05	0.00066	CcSEcCtD
Gadoxetate—Discomfort—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000659	CcSEcCtD
Gadoxetate—Skin disorder—Metformin—type 2 diabetes mellitus	9.21e-05	0.000658	CcSEcCtD
Gadoxetate—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.18e-05	0.000656	CcSEcCtD
Gadoxetate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.17e-05	0.000655	CcSEcCtD
Gadoxetate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000654	CcSEcCtD
Gadoxetate—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.13e-05	0.000652	CcSEcCtD
Gadoxetate—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000652	CcSEcCtD
Gadoxetate—Palpitations—Losartan—type 2 diabetes mellitus	9.12e-05	0.000651	CcSEcCtD
Gadoxetate—Nausea—Glimepiride—type 2 diabetes mellitus	9.09e-05	0.000649	CcSEcCtD
Gadoxetate—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.08e-05	0.000649	CcSEcCtD
Gadoxetate—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.07e-05	0.000648	CcSEcCtD
Gadoxetate—Nausea—Sitagliptin—type 2 diabetes mellitus	9.07e-05	0.000647	CcSEcCtD
Gadoxetate—Asthenia—Glyburide—type 2 diabetes mellitus	9.06e-05	0.000647	CcSEcCtD
Gadoxetate—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.05e-05	0.000647	CcSEcCtD
Gadoxetate—Anorexia—Metformin—type 2 diabetes mellitus	9.04e-05	0.000646	CcSEcCtD
Gadoxetate—Cough—Losartan—type 2 diabetes mellitus	9.01e-05	0.000643	CcSEcCtD
Gadoxetate—Urticaria—Gliclazide—type 2 diabetes mellitus	9.01e-05	0.000643	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.99e-05	0.000642	CcSEcCtD
Gadoxetate—Fatigue—Valsartan—type 2 diabetes mellitus	8.98e-05	0.000641	CcSEcCtD
Gadoxetate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.00064	CcSEcCtD
Gadoxetate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.00064	CcSEcCtD
Gadoxetate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.000639	CcSEcCtD
Gadoxetate—Oedema—Irbesartan—type 2 diabetes mellitus	8.95e-05	0.000639	CcSEcCtD
Gadoxetate—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.95e-05	0.000639	CcSEcCtD
Gadoxetate—Pruritus—Glyburide—type 2 diabetes mellitus	8.93e-05	0.000638	CcSEcCtD
Gadoxetate—Constipation—Valsartan—type 2 diabetes mellitus	8.91e-05	0.000636	CcSEcCtD
Gadoxetate—Infection—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000635	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.89e-05	0.000635	CcSEcCtD
Gadoxetate—Fatigue—Orlistat—type 2 diabetes mellitus	8.87e-05	0.000634	CcSEcCtD
Gadoxetate—Hypotension—Metformin—type 2 diabetes mellitus	8.86e-05	0.000633	CcSEcCtD
Gadoxetate—Shock—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000629	CcSEcCtD
Gadoxetate—Chest pain—Losartan—type 2 diabetes mellitus	8.79e-05	0.000628	CcSEcCtD
Gadoxetate—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.78e-05	0.000627	CcSEcCtD
Gadoxetate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.000627	CcSEcCtD
Gadoxetate—Anxiety—Losartan—type 2 diabetes mellitus	8.76e-05	0.000625	CcSEcCtD
Gadoxetate—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000624	CcSEcCtD
Gadoxetate—Rash—Bromocriptine—type 2 diabetes mellitus	8.71e-05	0.000622	CcSEcCtD
Gadoxetate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.7e-05	0.000621	CcSEcCtD
Gadoxetate—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.7e-05	0.000621	CcSEcCtD
Gadoxetate—Discomfort—Losartan—type 2 diabetes mellitus	8.68e-05	0.00062	CcSEcCtD
Gadoxetate—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000619	CcSEcCtD
Gadoxetate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.65e-05	0.000618	CcSEcCtD
Gadoxetate—Headache—Bromocriptine—type 2 diabetes mellitus	8.65e-05	0.000618	CcSEcCtD
Gadoxetate—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.64e-05	0.000617	CcSEcCtD
Gadoxetate—Dry mouth—Losartan—type 2 diabetes mellitus	8.59e-05	0.000614	CcSEcCtD
Gadoxetate—Anorexia—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000609	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000608	CcSEcCtD
Gadoxetate—Paraesthesia—Metformin—type 2 diabetes mellitus	8.52e-05	0.000608	CcSEcCtD
Gadoxetate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.48e-05	0.000606	CcSEcCtD
Gadoxetate—Dyspnoea—Metformin—type 2 diabetes mellitus	8.46e-05	0.000604	CcSEcCtD
Gadoxetate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.42e-05	0.000602	CcSEcCtD
Gadoxetate—Oedema—Losartan—type 2 diabetes mellitus	8.42e-05	0.000602	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.42e-05	0.000601	CcSEcCtD
Gadoxetate—Infection—Losartan—type 2 diabetes mellitus	8.37e-05	0.000598	CcSEcCtD
Gadoxetate—Hypotension—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000597	CcSEcCtD
Gadoxetate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.35e-05	0.000597	CcSEcCtD
Gadoxetate—Tremor—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000592	CcSEcCtD
Gadoxetate—Shock—Losartan—type 2 diabetes mellitus	8.29e-05	0.000592	CcSEcCtD
Gadoxetate—Urticaria—Valsartan—type 2 diabetes mellitus	8.28e-05	0.000591	CcSEcCtD
Gadoxetate—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.26e-05	0.00059	CcSEcCtD
Gadoxetate—Decreased appetite—Metformin—type 2 diabetes mellitus	8.25e-05	0.000589	CcSEcCtD
Gadoxetate—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.23e-05	0.000588	CcSEcCtD
Gadoxetate—Tachycardia—Losartan—type 2 diabetes mellitus	8.22e-05	0.000587	CcSEcCtD
Gadoxetate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000586	CcSEcCtD
Gadoxetate—Nausea—Bromocriptine—type 2 diabetes mellitus	8.2e-05	0.000586	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.19e-05	0.000585	CcSEcCtD
Gadoxetate—Fatigue—Metformin—type 2 diabetes mellitus	8.18e-05	0.000584	CcSEcCtD
Gadoxetate—Urticaria—Orlistat—type 2 diabetes mellitus	8.18e-05	0.000584	CcSEcCtD
Gadoxetate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.14e-05	0.000582	CcSEcCtD
Gadoxetate—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000581	CcSEcCtD
Gadoxetate—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000581	CcSEcCtD
Gadoxetate—Asthenia—Gliclazide—type 2 diabetes mellitus	8.13e-05	0.000581	CcSEcCtD
Gadoxetate—Agitation—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000581	CcSEcCtD
Gadoxetate—Constipation—Metformin—type 2 diabetes mellitus	8.11e-05	0.000579	CcSEcCtD
Gadoxetate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000574	CcSEcCtD
Gadoxetate—Anorexia—Losartan—type 2 diabetes mellitus	8.03e-05	0.000574	CcSEcCtD
Gadoxetate—Vomiting—Glyburide—type 2 diabetes mellitus	8.03e-05	0.000573	CcSEcCtD
Gadoxetate—Pruritus—Gliclazide—type 2 diabetes mellitus	8.02e-05	0.000573	CcSEcCtD
Gadoxetate—Malaise—Ramipril—type 2 diabetes mellitus	7.98e-05	0.00057	CcSEcCtD
Gadoxetate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.98e-05	0.00057	CcSEcCtD
Gadoxetate—Rash—Glyburide—type 2 diabetes mellitus	7.96e-05	0.000569	CcSEcCtD
Gadoxetate—Dermatitis—Glyburide—type 2 diabetes mellitus	7.95e-05	0.000568	CcSEcCtD
Gadoxetate—Vertigo—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000568	CcSEcCtD
Gadoxetate—Syncope—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000567	CcSEcCtD
Gadoxetate—Headache—Glyburide—type 2 diabetes mellitus	7.91e-05	0.000565	CcSEcCtD
Gadoxetate—Hypotension—Losartan—type 2 diabetes mellitus	7.87e-05	0.000562	CcSEcCtD
Gadoxetate—Palpitations—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000559	CcSEcCtD
Gadoxetate—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.82e-05	0.000558	CcSEcCtD
Gadoxetate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000556	CcSEcCtD
Gadoxetate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000556	CcSEcCtD
Gadoxetate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.76e-05	0.000554	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.76e-05	0.000554	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.000552	CcSEcCtD
Gadoxetate—Cough—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000552	CcSEcCtD
Gadoxetate—Fatigue—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000551	CcSEcCtD
Gadoxetate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.67e-05	0.000548	CcSEcCtD
Gadoxetate—Convulsion—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000548	CcSEcCtD
Gadoxetate—Constipation—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000547	CcSEcCtD
Gadoxetate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.58e-05	0.000542	CcSEcCtD
Gadoxetate—Paraesthesia—Losartan—type 2 diabetes mellitus	7.56e-05	0.00054	CcSEcCtD
Gadoxetate—Urticaria—Metformin—type 2 diabetes mellitus	7.54e-05	0.000538	CcSEcCtD
Gadoxetate—Chest pain—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000538	CcSEcCtD
Gadoxetate—Dyspnoea—Losartan—type 2 diabetes mellitus	7.51e-05	0.000536	CcSEcCtD
Gadoxetate—Anxiety—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000536	CcSEcCtD
Gadoxetate—Nausea—Glyburide—type 2 diabetes mellitus	7.5e-05	0.000536	CcSEcCtD
Gadoxetate—Abdominal pain—Metformin—type 2 diabetes mellitus	7.5e-05	0.000536	CcSEcCtD
Gadoxetate—Dizziness—Gliclazide—type 2 diabetes mellitus	7.5e-05	0.000535	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000534	CcSEcCtD
Gadoxetate—Asthenia—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000534	CcSEcCtD
Gadoxetate—Discomfort—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000532	CcSEcCtD
Gadoxetate—Asthenia—Orlistat—type 2 diabetes mellitus	7.38e-05	0.000527	CcSEcCtD
Gadoxetate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000527	CcSEcCtD
Gadoxetate—Pruritus—Valsartan—type 2 diabetes mellitus	7.37e-05	0.000526	CcSEcCtD
Gadoxetate—Dry mouth—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000526	CcSEcCtD
Gadoxetate—Decreased appetite—Losartan—type 2 diabetes mellitus	7.32e-05	0.000523	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000523	CcSEcCtD
Gadoxetate—Pruritus—Orlistat—type 2 diabetes mellitus	7.28e-05	0.00052	CcSEcCtD
Gadoxetate—Fatigue—Losartan—type 2 diabetes mellitus	7.26e-05	0.000519	CcSEcCtD
Gadoxetate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000516	CcSEcCtD
Gadoxetate—Oedema—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000516	CcSEcCtD
Gadoxetate—Vomiting—Gliclazide—type 2 diabetes mellitus	7.21e-05	0.000515	CcSEcCtD
Gadoxetate—Constipation—Losartan—type 2 diabetes mellitus	7.2e-05	0.000514	CcSEcCtD
Gadoxetate—Rash—Gliclazide—type 2 diabetes mellitus	7.15e-05	0.000511	CcSEcCtD
Gadoxetate—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.14e-05	0.00051	CcSEcCtD
Gadoxetate—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.13e-05	0.000509	CcSEcCtD
Gadoxetate—Urticaria—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000508	CcSEcCtD
Gadoxetate—Shock—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000508	CcSEcCtD
Gadoxetate—Headache—Gliclazide—type 2 diabetes mellitus	7.1e-05	0.000507	CcSEcCtD
Gadoxetate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000506	CcSEcCtD
Gadoxetate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000505	CcSEcCtD
Gadoxetate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000505	CcSEcCtD
Gadoxetate—Tachycardia—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000503	CcSEcCtD
Gadoxetate—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.04e-05	0.000503	CcSEcCtD
Gadoxetate—Skin disorder—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000501	CcSEcCtD
Gadoxetate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000499	CcSEcCtD
Gadoxetate—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.94e-05	0.000496	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.89e-05	0.000492	CcSEcCtD
Gadoxetate—Dizziness—Valsartan—type 2 diabetes mellitus	6.89e-05	0.000492	CcSEcCtD
Gadoxetate—Anorexia—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000492	CcSEcCtD
Gadoxetate—Dizziness—Orlistat—type 2 diabetes mellitus	6.81e-05	0.000486	CcSEcCtD
Gadoxetate—Asthenia—Metformin—type 2 diabetes mellitus	6.81e-05	0.000486	CcSEcCtD
Gadoxetate—Hypotension—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000482	CcSEcCtD
Gadoxetate—Nausea—Gliclazide—type 2 diabetes mellitus	6.73e-05	0.000481	CcSEcCtD
Gadoxetate—Pruritus—Metformin—type 2 diabetes mellitus	6.71e-05	0.000479	CcSEcCtD
Gadoxetate—Urticaria—Losartan—type 2 diabetes mellitus	6.69e-05	0.000478	CcSEcCtD
Gadoxetate—Abdominal pain—Losartan—type 2 diabetes mellitus	6.66e-05	0.000476	CcSEcCtD
Gadoxetate—Body temperature increased—Losartan—type 2 diabetes mellitus	6.66e-05	0.000476	CcSEcCtD
Gadoxetate—Vomiting—Valsartan—type 2 diabetes mellitus	6.62e-05	0.000473	CcSEcCtD
Gadoxetate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.000471	CcSEcCtD
Gadoxetate—Rash—Valsartan—type 2 diabetes mellitus	6.57e-05	0.000469	CcSEcCtD
Gadoxetate—Dermatitis—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000469	CcSEcCtD
Gadoxetate—Vomiting—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000467	CcSEcCtD
Gadoxetate—Headache—Valsartan—type 2 diabetes mellitus	6.53e-05	0.000466	CcSEcCtD
Gadoxetate—Diarrhoea—Metformin—type 2 diabetes mellitus	6.49e-05	0.000464	CcSEcCtD
Gadoxetate—Rash—Orlistat—type 2 diabetes mellitus	6.49e-05	0.000463	CcSEcCtD
Gadoxetate—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000463	CcSEcCtD
Gadoxetate—Dermatitis—Orlistat—type 2 diabetes mellitus	6.48e-05	0.000463	CcSEcCtD
Gadoxetate—Headache—Orlistat—type 2 diabetes mellitus	6.45e-05	0.000461	CcSEcCtD
Gadoxetate—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.44e-05	0.00046	CcSEcCtD
Gadoxetate—Asthenia—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000459	CcSEcCtD
Gadoxetate—Pruritus—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000452	CcSEcCtD
Gadoxetate—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000448	CcSEcCtD
Gadoxetate—Dizziness—Metformin—type 2 diabetes mellitus	6.27e-05	0.000448	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000445	CcSEcCtD
Gadoxetate—Fatigue—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000445	CcSEcCtD
Gadoxetate—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.21e-05	0.000443	CcSEcCtD
Gadoxetate—Nausea—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000442	CcSEcCtD
Gadoxetate—Constipation—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000441	CcSEcCtD
Gadoxetate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000437	CcSEcCtD
Gadoxetate—Nausea—Orlistat—type 2 diabetes mellitus	6.11e-05	0.000437	CcSEcCtD
Gadoxetate—Asthenia—Losartan—type 2 diabetes mellitus	6.04e-05	0.000432	CcSEcCtD
Gadoxetate—Vomiting—Metformin—type 2 diabetes mellitus	6.03e-05	0.000431	CcSEcCtD
Gadoxetate—Rash—Metformin—type 2 diabetes mellitus	5.98e-05	0.000427	CcSEcCtD
Gadoxetate—Dermatitis—Metformin—type 2 diabetes mellitus	5.98e-05	0.000427	CcSEcCtD
Gadoxetate—Pruritus—Losartan—type 2 diabetes mellitus	5.96e-05	0.000426	CcSEcCtD
Gadoxetate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000425	CcSEcCtD
Gadoxetate—Headache—Metformin—type 2 diabetes mellitus	5.94e-05	0.000424	CcSEcCtD
Gadoxetate—Dizziness—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.000423	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000422	CcSEcCtD
Gadoxetate—Diarrhoea—Losartan—type 2 diabetes mellitus	5.76e-05	0.000412	CcSEcCtD
Gadoxetate—Urticaria—Ramipril—type 2 diabetes mellitus	5.74e-05	0.00041	CcSEcCtD
Gadoxetate—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000408	CcSEcCtD
Gadoxetate—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000408	CcSEcCtD
Gadoxetate—Vomiting—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000406	CcSEcCtD
Gadoxetate—Rash—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000403	CcSEcCtD
Gadoxetate—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000403	CcSEcCtD
Gadoxetate—Nausea—Metformin—type 2 diabetes mellitus	5.63e-05	0.000402	CcSEcCtD
Gadoxetate—Headache—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000401	CcSEcCtD
Gadoxetate—Dizziness—Losartan—type 2 diabetes mellitus	5.57e-05	0.000398	CcSEcCtD
Gadoxetate—Vomiting—Losartan—type 2 diabetes mellitus	5.36e-05	0.000383	CcSEcCtD
Gadoxetate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.32e-05	0.00038	CcSEcCtD
Gadoxetate—Nausea—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.00038	CcSEcCtD
Gadoxetate—Rash—Losartan—type 2 diabetes mellitus	5.31e-05	0.000379	CcSEcCtD
Gadoxetate—Dermatitis—Losartan—type 2 diabetes mellitus	5.31e-05	0.000379	CcSEcCtD
Gadoxetate—Headache—Losartan—type 2 diabetes mellitus	5.28e-05	0.000377	CcSEcCtD
Gadoxetate—Asthenia—Ramipril—type 2 diabetes mellitus	5.18e-05	0.00037	CcSEcCtD
Gadoxetate—Pruritus—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000365	CcSEcCtD
Gadoxetate—Nausea—Losartan—type 2 diabetes mellitus	5e-05	0.000357	CcSEcCtD
Gadoxetate—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000353	CcSEcCtD
Gadoxetate—Dizziness—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000341	CcSEcCtD
Gadoxetate—Vomiting—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000328	CcSEcCtD
Gadoxetate—Rash—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000325	CcSEcCtD
Gadoxetate—Dermatitis—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000325	CcSEcCtD
Gadoxetate—Headache—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000323	CcSEcCtD
Gadoxetate—Nausea—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000306	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—OXCT1—type 2 diabetes mellitus	2.61e-05	0.000489	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYTB—type 2 diabetes mellitus	2.61e-05	0.000489	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PPP2CA—type 2 diabetes mellitus	2.61e-05	0.000488	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.61e-05	0.000488	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.59e-05	0.000484	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HK1—type 2 diabetes mellitus	2.56e-05	0.000479	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.56e-05	0.000479	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.55e-05	0.000477	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SRD5A1—type 2 diabetes mellitus	2.55e-05	0.000476	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.53e-05	0.000474	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.52e-05	0.000472	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.51e-05	0.000469	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.51e-05	0.000469	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	2.51e-05	0.000469	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.5e-05	0.000468	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HSD3B2—type 2 diabetes mellitus	2.47e-05	0.000463	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—KCNJ11—type 2 diabetes mellitus	2.47e-05	0.000463	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GCKR—type 2 diabetes mellitus	2.47e-05	0.000463	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LPA—type 2 diabetes mellitus	2.47e-05	0.000463	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.47e-05	0.000462	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.46e-05	0.000461	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GLP1R—type 2 diabetes mellitus	2.44e-05	0.000457	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	2.44e-05	0.000456	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ACACA—type 2 diabetes mellitus	2.43e-05	0.000455	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—STAR—type 2 diabetes mellitus	2.43e-05	0.000455	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD17B3—type 2 diabetes mellitus	2.43e-05	0.000455	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.43e-05	0.000454	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MMP1—type 2 diabetes mellitus	2.41e-05	0.000451	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.38e-05	0.000445	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALDOB—type 2 diabetes mellitus	2.37e-05	0.000444	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.36e-05	0.000441	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.35e-05	0.00044	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CALM1—type 2 diabetes mellitus	2.34e-05	0.000437	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCC8—type 2 diabetes mellitus	2.33e-05	0.000436	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CBS—type 2 diabetes mellitus	2.33e-05	0.000436	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—APOA1—type 2 diabetes mellitus	2.3e-05	0.000431	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.3e-05	0.000431	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A2—type 2 diabetes mellitus	2.28e-05	0.000427	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.26e-05	0.000423	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.26e-05	0.000422	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A2—type 2 diabetes mellitus	2.24e-05	0.00042	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—COX2—type 2 diabetes mellitus	2.24e-05	0.00042	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	2.24e-05	0.000419	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CPT1A—type 2 diabetes mellitus	2.24e-05	0.000418	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTR—type 2 diabetes mellitus	2.24e-05	0.000418	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.23e-05	0.000417	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.23e-05	0.000417	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.22e-05	0.000415	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GLP1R—type 2 diabetes mellitus	2.21e-05	0.000412	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOA6—type 2 diabetes mellitus	2.2e-05	0.000412	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.2e-05	0.000412	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.2e-05	0.000411	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PRKCB—type 2 diabetes mellitus	2.2e-05	0.000411	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NAMPT—type 2 diabetes mellitus	2.19e-05	0.00041	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.18e-05	0.000408	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HBA1—type 2 diabetes mellitus	2.18e-05	0.000407	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LIPC—type 2 diabetes mellitus	2.18e-05	0.000407	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GCK—type 2 diabetes mellitus	2.18e-05	0.000407	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS2—type 2 diabetes mellitus	2.17e-05	0.000406	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD11B1—type 2 diabetes mellitus	2.17e-05	0.000405	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UCP3—type 2 diabetes mellitus	2.17e-05	0.000405	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UCP2—type 2 diabetes mellitus	2.17e-05	0.000405	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP11A1—type 2 diabetes mellitus	2.16e-05	0.000405	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.13e-05	0.000398	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.13e-05	0.000398	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC9A1—type 2 diabetes mellitus	2.13e-05	0.000398	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.12e-05	0.000397	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CETP—type 2 diabetes mellitus	2.1e-05	0.000393	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.1e-05	0.000393	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.09e-05	0.000392	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.08e-05	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.07e-05	0.000386	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A2—type 2 diabetes mellitus	2.06e-05	0.000385	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PCK1—type 2 diabetes mellitus	2.04e-05	0.000381	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CPT1A—type 2 diabetes mellitus	2.02e-05	0.000377	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTR—type 2 diabetes mellitus	2.02e-05	0.000377	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.01e-05	0.000375	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2e-05	0.000373	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.99e-05	0.000373	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.99e-05	0.000372	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NAMPT—type 2 diabetes mellitus	1.98e-05	0.00037	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.97e-05	0.000368	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HBA1—type 2 diabetes mellitus	1.97e-05	0.000368	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LIPC—type 2 diabetes mellitus	1.97e-05	0.000368	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GCK—type 2 diabetes mellitus	1.97e-05	0.000368	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.96e-05	0.000366	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.96e-05	0.000366	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PSMD6—type 2 diabetes mellitus	1.95e-05	0.000365	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SREBF1—type 2 diabetes mellitus	1.95e-05	0.000365	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SNAP25—type 2 diabetes mellitus	1.95e-05	0.000365	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP11A1—type 2 diabetes mellitus	1.95e-05	0.000365	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF1—type 2 diabetes mellitus	1.93e-05	0.00036	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT2—type 2 diabetes mellitus	1.92e-05	0.00036	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC9A1—type 2 diabetes mellitus	1.92e-05	0.000359	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CTGF—type 2 diabetes mellitus	1.92e-05	0.000359	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HK1—type 2 diabetes mellitus	1.91e-05	0.000357	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.91e-05	0.000356	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMGCR—type 2 diabetes mellitus	1.9e-05	0.000355	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CETP—type 2 diabetes mellitus	1.9e-05	0.000355	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.87e-05	0.00035	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.87e-05	0.000349	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.86e-05	0.000348	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ADRA2A—type 2 diabetes mellitus	1.86e-05	0.000348	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GCKR—type 2 diabetes mellitus	1.84e-05	0.000344	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.84e-05	0.000344	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.84e-05	0.000344	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LPA—type 2 diabetes mellitus	1.84e-05	0.000344	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.83e-05	0.000342	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ALB—type 2 diabetes mellitus	1.83e-05	0.000341	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.79e-05	0.000335	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2E1—type 2 diabetes mellitus	1.79e-05	0.000334	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.77e-05	0.000331	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.77e-05	0.000331	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A1—type 2 diabetes mellitus	1.77e-05	0.00033	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A2—type 2 diabetes mellitus	1.77e-05	0.00033	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALDOB—type 2 diabetes mellitus	1.77e-05	0.00033	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PSMD6—type 2 diabetes mellitus	1.76e-05	0.00033	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SNAP25—type 2 diabetes mellitus	1.76e-05	0.00033	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SREBF1—type 2 diabetes mellitus	1.76e-05	0.00033	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.75e-05	0.000327	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS3—type 2 diabetes mellitus	1.75e-05	0.000327	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CTGF—type 2 diabetes mellitus	1.73e-05	0.000324	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP3A4—type 2 diabetes mellitus	1.72e-05	0.000322	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.72e-05	0.000321	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMGCR—type 2 diabetes mellitus	1.71e-05	0.000321	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.71e-05	0.000321	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GCG—type 2 diabetes mellitus	1.69e-05	0.000317	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A4—type 2 diabetes mellitus	1.69e-05	0.000317	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.69e-05	0.000316	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.68e-05	0.000315	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.68e-05	0.000315	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.68e-05	0.000314	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.68e-05	0.000314	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ADRA2A—type 2 diabetes mellitus	1.68e-05	0.000314	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.66e-05	0.000311	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GLP1R—type 2 diabetes mellitus	1.64e-05	0.000307	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2E1—type 2 diabetes mellitus	1.61e-05	0.000302	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A2—type 2 diabetes mellitus	1.59e-05	0.000298	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A1—type 2 diabetes mellitus	1.59e-05	0.000298	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.58e-05	0.000296	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.58e-05	0.000295	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.56e-05	0.000291	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP3A4—type 2 diabetes mellitus	1.55e-05	0.000291	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.55e-05	0.000289	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.53e-05	0.000287	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A4—type 2 diabetes mellitus	1.53e-05	0.000286	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GCG—type 2 diabetes mellitus	1.53e-05	0.000286	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTR—type 2 diabetes mellitus	1.5e-05	0.000281	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CPT1A—type 2 diabetes mellitus	1.5e-05	0.000281	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NAMPT—type 2 diabetes mellitus	1.47e-05	0.000275	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.46e-05	0.000274	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HBA1—type 2 diabetes mellitus	1.46e-05	0.000274	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LIPC—type 2 diabetes mellitus	1.46e-05	0.000274	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GCK—type 2 diabetes mellitus	1.46e-05	0.000274	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNB3—type 2 diabetes mellitus	1.46e-05	0.000273	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.46e-05	0.000273	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.45e-05	0.000272	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMOX1—type 2 diabetes mellitus	1.45e-05	0.000272	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAT—type 2 diabetes mellitus	1.43e-05	0.000268	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.43e-05	0.000267	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CETP—type 2 diabetes mellitus	1.41e-05	0.000264	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOB—type 2 diabetes mellitus	1.39e-05	0.00026	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—type 2 diabetes mellitus	1.35e-05	0.000253	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.33e-05	0.000249	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—LPL—type 2 diabetes mellitus	1.33e-05	0.000249	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNB3—type 2 diabetes mellitus	1.32e-05	0.000246	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.32e-05	0.000246	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.32e-05	0.000246	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SREBF1—type 2 diabetes mellitus	1.31e-05	0.000245	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SNAP25—type 2 diabetes mellitus	1.31e-05	0.000245	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PSMD6—type 2 diabetes mellitus	1.31e-05	0.000245	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMOX1—type 2 diabetes mellitus	1.31e-05	0.000245	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ADCY5—type 2 diabetes mellitus	1.3e-05	0.000243	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPX1—type 2 diabetes mellitus	1.3e-05	0.000243	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAT—type 2 diabetes mellitus	1.29e-05	0.000242	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SRC—type 2 diabetes mellitus	1.29e-05	0.000242	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CTGF—type 2 diabetes mellitus	1.29e-05	0.000241	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HMGCR—type 2 diabetes mellitus	1.28e-05	0.000239	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CD36—type 2 diabetes mellitus	1.26e-05	0.000236	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.26e-05	0.000235	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—type 2 diabetes mellitus	1.26e-05	0.000235	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOB—type 2 diabetes mellitus	1.26e-05	0.000235	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.25e-05	0.000234	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.25e-05	0.000234	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.25e-05	0.000233	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTM1—type 2 diabetes mellitus	1.22e-05	0.000228	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.2e-05	0.000225	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—LPL—type 2 diabetes mellitus	1.2e-05	0.000224	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—type 2 diabetes mellitus	1.2e-05	0.000224	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.19e-05	0.000222	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.19e-05	0.000222	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARA—type 2 diabetes mellitus	1.17e-05	0.00022	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ADCY5—type 2 diabetes mellitus	1.17e-05	0.00022	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GPX1—type 2 diabetes mellitus	1.17e-05	0.000219	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.16e-05	0.000216	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—type 2 diabetes mellitus	1.15e-05	0.000216	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.15e-05	0.000215	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CD36—type 2 diabetes mellitus	1.14e-05	0.000213	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.14e-05	0.000213	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GCG—type 2 diabetes mellitus	1.14e-05	0.000213	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AGT—type 2 diabetes mellitus	1.14e-05	0.000213	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.13e-05	0.00021	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CALM1—type 2 diabetes mellitus	1.12e-05	0.000209	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOE—type 2 diabetes mellitus	1.11e-05	0.000208	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOA1—type 2 diabetes mellitus	1.1e-05	0.000206	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—type 2 diabetes mellitus	1.08e-05	0.000202	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARA—type 2 diabetes mellitus	1.06e-05	0.000198	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AGT—type 2 diabetes mellitus	1.03e-05	0.000192	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CALM1—type 2 diabetes mellitus	1.01e-05	0.000189	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOE—type 2 diabetes mellitus	1.01e-05	0.000188	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOA1—type 2 diabetes mellitus	9.94e-06	0.000186	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	9.81e-06	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.81e-06	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	9.76e-06	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—type 2 diabetes mellitus	9.7e-06	0.000181	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	9.63e-06	0.00018	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—INS—type 2 diabetes mellitus	9.52e-06	0.000178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	9.35e-06	0.000175	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	9.1e-06	0.00017	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	8.93e-06	0.000167	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—type 2 diabetes mellitus	8.76e-06	0.000164	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	8.74e-06	0.000163	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—type 2 diabetes mellitus	8.73e-06	0.000163	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	8.71e-06	0.000163	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—INS—type 2 diabetes mellitus	8.59e-06	0.000161	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	8.49e-06	0.000159	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.38e-06	0.000157	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3R1—type 2 diabetes mellitus	8.35e-06	0.000156	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NOS3—type 2 diabetes mellitus	8.35e-06	0.000156	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	8.04e-06	0.00015	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	8.03e-06	0.00015	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	7.89e-06	0.000148	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—type 2 diabetes mellitus	7.87e-06	0.000147	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	7.64e-06	0.000143	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	7.63e-06	0.000143	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NOS3—type 2 diabetes mellitus	7.53e-06	0.000141	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3R1—type 2 diabetes mellitus	7.53e-06	0.000141	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	7.51e-06	0.00014	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	7.49e-06	0.00014	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	7.4e-06	0.000138	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—type 2 diabetes mellitus	6.89e-06	0.000129	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	6.52e-06	0.000122	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	6.4e-06	0.00012	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	5.86e-06	0.00011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.61e-06	0.000105	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	5.61e-06	0.000105	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	5.13e-06	9.59e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	3.84e-06	7.18e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	3.46e-06	6.47e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	2.58e-06	4.82e-05	CbGpPWpGaD
